Video Experimental Relacionado
Updated: Aug 2, 2026
09:29
Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
Un nuevo agente promotor de tumores, la dihidroteleocidina B, mejora notablemente la transformación de células
Science (New York, N.Y.)
|April 30, 1982
Resumen
La dihidroteleocidina B, un compuesto derivado de Streptomyces, mejora significativamente la transformación de las células malignas. Es más de 100 veces más potente que el 12-O-tetradecanoil-forbol-13-acetato para promover cambios celulares.
Área de la Ciencia:
- Oncología Oncología.
- Dermatología Dermatología dermatología.
- La bioquímica es la bioquímica.
Sus antecedentes:
- La teleocidina es un potente promotor de tumores aislado de Streptomyces.
- La comprensión de los mecanismos de promoción tumoral es crucial en la investigación del cáncer.
Objetivo del estudio:
- Para investigar la actividad promotora de tumores de la dihidroteleocidina B.
- Para comparar la eficacia de la dihidroteleocidina B con promotores conocidos.
Principales métodos:
- Hidrogenación catalítica de la teleocidina a la dihidroteleocidina B. Por ejemplo:
- Inducción de la transformación de células malignas mediante el uso de sustancias químicas cancerígenas (3-metilcolantreno) o radiación ultravioleta en modelos de piel de ratón.
- Evaluación de los efectos tempranos de la membrana y la síntesis del ADN.
Principales resultados:
- La dihidroteleocidina B mejoró notablemente la transformación de las células malignas.
- La dihidroteleocidina B fue más de 100 veces más efectiva que el 12-O-tetradecanoil-forbol-13-acetato (TPA) para mejorar la transformación.
- Tanto la dihidroteleocidina B como el TPA indujeron efectos similares en la membrana temprana y en la síntesis del ADN.
Conclusiones:
- La dihidroteleocidina B es un promotor de tumores muy potente.
- La dihidroteleocidina B representa una nueva y poderosa herramienta para el estudio de la carcinogénesis.
- Se necesita más investigación sobre el mecanismo de acción de la dihidroteleocidina B.
Más Videos Relacionados
![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)
Videos de Conceptos Relacionados
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
01:25Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.